세계 휴대용 진단 기기 시장 예측(-2030년)

Market Overview

Portable Diagnostic Devices Market is projected to register a healthy CAGR of 9.04% during the review period. The developing mechanical progressions and expanding frequencies of persistent infections are driving market development.

The developing mechanical progressions in portable diagnostics offer advantages like reasonableness, patient wellbeing, and fast and quality conclusion. The market players are bringing new innovations into portable devices, like 3D ultrasound, high level elements and apparatuses at fingertips, and remote ultrasound, which are driving the market's development. For example, February 2023: Mindray (China) sent off the remote handheld ultrasound framework TE Air, which is explicitly intended to satisfy the need of worldwide medical services experts. It is easy to use in various clinical settings and gives clear place of-care ultrasound (POCUS) imaging.

Moreover, the ascent in ongoing sicknesses is a basic element pushing market development. Malignant growth, coronary illness, diabetes, weight, and constant respiratory infections are among the most well-known and quickly expanding ongoing sicknesses. In September 2022, the Worldwide Drive for Ongoing Obstructive Cellular breakdown in the lungs reported that around 200 million individuals overall have persistent obstructive pneumonic sickness (COPD) and 262 million individuals are impacted by asthma every year.

Market Segmentation

Portable diagnostic devices market segmentation is based on type and is divided into diagnostic imaging devices and monitoring devices. Portable diagnostic devices market segmentation is based on applications divided into gynecology, cardiology, gastrointestinal, urology, neurology, respiratory, orthopedics, ophthalmology and others. The segmentation of the portable diagnostic devices market is based on the division of end users into hospitals and hospitals. Clinics, diagnostic centers, home care facilities and others. The hospitals and clinics segment dominated the market in 2022 and projected to be the fastest-growing during the forecast period, 2023-2030.

Regional Analysis

The North America Portable Diagnostic Devices market represented the biggest market share owing to the rising interest for portable devices, high treatment rates, and steady government drives for early finding of illnesses is additionally expected to cultivate North America's market development.

Europe Portable Diagnostic Devices market is anticipated to register the second-biggest market in future. The regional growth is drien by the Rising reception of cutting edge clinical devices, high treatment rates and steady government drives for early infection discovery is additionally expected to help the development of the market.

The Asia-Pacific Portable Diagnostic Devices market is supposed to develop at a critical offer from 2023 to 2030. This is because of variables like the ascent in the geriatric populace, the developing predominance of diabetes, raising occurrences of heart sicknesses, and an expansion in extra cash alongside the reception of brilliant wearables is additionally expected to support the market development.

Major Players

Key Companies in the Portable Diagnostic Devices Market are Hoffmann-La Roche Ltd, GE Healthcare, Medtronic, Omron Healthcare Inc., Koninklijke Philips N.V., Abbott, COM, Stryker, Wellue, and EMAY.

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 OVERVIEW

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE
• 2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

• 3.1 DATA MINING
• 3.2 SECONDARY RESEARCH
• 3.3 PRIMARY RESEARCH
• 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5 FORECASTING TECHNIQUES
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.6.1 BOTTOM-UP APPROACH
  • 3.6.2 TOP-DOWN APPROACH
• 3.7 DATA TRIANGULATION
• 3.8 VALIDATION

4 MARKET DYNAMICS

• 4.1 OVERVIEW
• 4.2 DRIVERS
  • 4.2.1 GROWING TECHNOLOGICAL ADVANCEMENTS
  • 4.2.2 INCREASING INCIDENCES OF CHRONIC DISEASES
• 4.3 RESTRAINTS
  • 4.3.1 LACK OF KNOWLEDGE TO RUN PORTABLE DIAGNOSTIC DEVICES IS A HINDRANCE TO THE MARKET
• 4.4 OPPORTUNITIES
  • 4.4.1 INCREASING FUNDING AND INVESTMENT THROUGH A PUBLIC AND PRIVATE ORGANIZATIONS

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 R&D & DESIGNING
  • 5.1.2 MANUFACTURING
  • 5.1.3 DISTRIBUTION & SALES
  • 5.1.4 POST-SALES MONITORING
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 IMPACT OF COVID-19 ON THE GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET
  • 5.3.1 IMPACT ON SUPPLY CHAIN
  • 5.3.2 IMPACT ON PRODUCTION
  • 5.3.3 IMPACT ON REGIONS
  • 5.3.4 IMPACT ON SUPPLY GAP ANALYSIS
  • 5.3.5 IMPACT ON PRICING

6 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY TYPE

• 6.1 OVERVIEW
• 6.2 DIAGNOSTIC IMAGING
  • 6.2.1. CT Scan
  • 6.2.2. X-Ray
  • 6.2.3. Ultrasound
  • 6.2.4. Endoscopes
• 6.3. MONITORING DEVICES
  • 6.3.1. Cardiac Monitoring
    • 6.3.1.1. Holter Monitors
    • 6.3.1.2. Resting ECG System
    • 6.3.1.3. Stress ECG Monitors
    • 6.3.1.4. Event Monitoring Systems
    • 6.3.1.5. ECG Management Systems
  • 6.3.2. Neuromonitoring
    • 6.3.2.1. EEG Machines
    • 6.3.2.2. EMG Machines
    • 6.3.2.3. ICP Monitors
    • 6.3.2.4. MEG Machines
    • 6.3.2.5. Cerebral Oximeters
  • 6.3.3. Respiratory Monitoring
    • 6.3.3.1. Capnographs
    • 6.3.3.2. Spirometers
    • 6.3.3.3. Peak Flow Meters
  • 6.3.4. Ophthalmic Monitoring
    • 6.3.4.1. Fundus Cameras
    • 6.3.4.2. Tonometry Devices
    • 6.3.4.3. Others
  • 6.3.5. Hemodynamic Monitoring Systems
  • 6.3.6. Vital Sign Monitors
  • 6.3.7. Smart Wearable Medical Device
  • 6.3.8. Others

7 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY APPLICATION

• 7.1 OVERVIEW
• 7.2 GYNAECOLOGY
• 7.3 CARDIOLOGY
• 7.4 GASTROINTESTINAL
• 7.5 UROLOGY
• 7.6 NEUROLOGY
• 7.7 RESPIRATORY
• 7.8 ORTHOPEDICS
• 7.9 OPTHALMOLOGY
• 7.10 OTHERS

8 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY END USER

• 8.1 OVERVIEW
• 8.2 HOSPITALS & CLINICS
• 8.3 DIAGNOSTIC CENTERS
• 8.4 HOMECARE SETTINGS
• 8.5 OTHERS

9 GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 GLOBAL
• 9.3 NORTH AMERICA
  • 9.3.1 US
  • 9.3.2 CANADA
• 9.4 EUROPE
  • 9.4.1 GERMANY
  • 9.4.2 UK
  • 9.4.3 FRANCE
  • 9.4.4 ITALY
  • 9.4.5 SPAIN
  • 9.4.6 REST OF EUROPE
• 9.5 ASIA-PACIFIC
  • 9.5.1 CHINA
  • 9.5.2 INDIA
  • 9.5.3 JAPAN
  • 9.5.4 AUSTRALIA
  • 9.5.5 SOUTH KOREA
  • 9.5.6 REST OF ASIA-PACIFIC
• 9.6 REST OF THE WORLD
  • 9.6.1 MIDDLE EAST
  • 9.6.2 AFRICA
  • 9.6.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 COMPETITIVE BENCHMARKING
• 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET
• 10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL PORTABLE DIAGNOSTIC DEVICES MARKET
• 10.5 KEY DEVELOPMENT ANALYSIS
• 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
  • 10.6.2 PARTNERSHIP/ AGREEMENT/COLLABORATION
• 10.7 MAJOR PLAYERS SALES ANALYSIS
  • 10.7.1 SALES & OPERATING INCOME
• 10.8 MAJOR PLAYERS R&D ANALYSIS

11 COMPANY PROFILE

• 11.1 F. HOFFMANN-LA ROCHE LTD
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 PRODUCTS OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 KEY STRATEGIES
• 11.2 GE HEALTHCARE
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 PRODUCTS OFFERED
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 SWOT ANALYSIS
  • 11.2.6 KEY STRATEGIES
• 11.3 MEDTRONIC
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 PRODUCTS OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 SWOT ANALYSIS
  • 11.3.6 KEY STRATEGIES
• 11.4 OMRON HEALTHCARE, INC.
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 PRODUCTS OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 KEY STRATEGIES
• 11.5 KONINKLIJKE PHILIPS N.V.
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 SWOT ANALYSIS
  • 11.5.6 KEY STRATEGIES
• 11.6 ABBOTT
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 PRODUCTS OFFERED
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 SWOT ANALYSIS
  • 11.6.6 KEY STRATEGIES
• 11.7 SAMSUNGHEALTHCARE.COM
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 KEY STRATEGIES
• 11.8 STRYKER
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 PRODUCTS OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 KEY STRATEGIES
• 11.9 WELLUE
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 KEY STRATEGIES
• 11.10 EMAY
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 PRODUCTS OFFERED
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 KEY STRATEGIES